Prescient Therapeutics Ltd. announced that it has appointed Steven Yatomi-Clarke as Chief Executive Officer and Managing Director of the company. Steven has a distinguished career in the Australian capital markets with a particular focus on the life sciences sector, where he has played a leading role as both a corporate advisor and fund raiser to many biotechnology companies.